These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2568779)

  • 1. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis.
    Kierdorf H; Kindler J; Winterscheid R; Hollmann HJ; Vorwerk D; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():119-23. PubMed ID: 2568779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
    Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
    Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of iohexol, iopamidol, iopromide, and iosimide compared with meglumine diatrizoate.
    Hartwig P; Mützel W; Taenzer V
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():220-3. PubMed ID: 2568800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validity of iohexol clearance in patients with chronic renal failure and normal renal function in comparison to (99m)Tc-DTPA-clearance].
    Wiendieck E; Hartung R; Fünfstück R; Keil E; Gottschild D; Stein G
    Dtsch Med Wochenschr; 2003 Jan; 128(3):76-80. PubMed ID: 12529836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iohexol clearance for GFR-determination in renal failure--single or multiple plasma sampling?
    Sterner G; Frennby B; Hultberg B; Almen T
    Nephrol Dial Transplant; 1996 Mar; 11(3):521-5. PubMed ID: 8671824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal excretion of iopromide and iopamidol after intravenous administration in digital subtraction angiography.
    Mützel W; Langer M; Keysser R
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():101-4. PubMed ID: 2568774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced iopromide elimination in hemodialysis with cuprophan membranes.
    Matzkies FK; Reinecke H; Tombach B; Koeneke J; Hohage H; Kisters K; Schaefer RM
    Acta Radiol; 2000 Nov; 41(6):671-3. PubMed ID: 11092496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of iopromide reduction rates during haemodialysis using an in vitro dialysis system.
    Teraoka T; Sugai T; Nakamura S; Hirasawa H; Oda S; Shiga H; Suga M; Yamane S; Ishii H; Yamagata S; Satoh N; Ueda S
    Nephrol Dial Transplant; 2005 Apr; 20(4):754-9. PubMed ID: 15687110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.
    Waaler A; Svaland M; Fauchald P; Jakobsen JA; Kolmannskog F; Berg KJ
    Nephron; 1990; 56(1):81-5. PubMed ID: 2234253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of low-osmolality contrast media by hemodialysis.
    Furukawa T; Ueda J; Takahashi S; Sakaguchi K
    Acta Radiol; 1996 Nov; 37(6):966-71. PubMed ID: 8995475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function.
    Moon SS; Bäck SE; Kurkus J; Nilsson-Ehle P
    Nephron; 1995; 70(4):430-7. PubMed ID: 7477648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validity of iohexol clearance in chronic renal failure and in normal kidney function in comparison with 99mTc-DTPA clearance].
    Mertz P
    Dtsch Med Wochenschr; 2003 Mar; 128(13):689-90; author reply 690. PubMed ID: 12660906
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance of iopromide during haemodialysis with high- and low-flux membranes.
    Matzkies FK; Tombach B; Kisters K; Schuhmann G; Hohage H; Schaefer RM
    Acta Radiol; 1999 Mar; 40(2):220-3. PubMed ID: 10080739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast medium elimination by hemodialysis].
    Baars HG; Schabel J; Weiss M
    Z Urol Nephrol; 1984 Aug; 77(8):473-81. PubMed ID: 6495896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
    Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function.
    Matzkies FK; Reinecke H; Tombach B; Kosch M; Hegger K; Milius M; Hohage H; Kisters K; Kerber S; Schaefer RM
    Am J Nephrol; 2000; 20(4):300-4. PubMed ID: 10970983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prospective study on the effects of low-osmolar and nonionic contrast media on renal functions].
    Liu Y; Yang F; Hu G
    Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):733-6. PubMed ID: 11930676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iopromide dosage and urographic image quality: is there an optimal dose?
    Dominik R; Keysser R; Taenzer V
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():111-5. PubMed ID: 2568777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.